Scott Reents

Scott Reents

Director Financiero/CFO en TOBIRA THERAPEUTICS INC .

Fortuna: 8 M $ al 31/05/2026

59 años
Health Technology
Consumer Services

Perfil

Mr. Scott T.
Reents
is a President & Director at Cerevel Therapeutics Holdings, Inc., a Chief Financial Officer & Executive Vice President at AbbVie, Inc., a Chief Financial Officer at Tobira Therapeutics, Inc., a Manager at Pharmacyclics LLC, a President at Landos Biopharma, Inc., a President & Director at Allergan GI Corp., a President & Director at Allergan, Inc., a President & Director at Celsius Therapeutics, Inc. and a President & Director at Oculeve, Inc. He is on the Board of Directors at Cerevel Therapeutics Holdings, Inc., Allergan GI Corp., Allergan, Inc., Celsius Therapeutics, Inc. and Oculeve, Inc. Mr. Reents was previously employed as a Vice President-Tax by Abbott Laboratories.
He received his undergraduate degree from the University of Nebraska, a graduate degree from the University of Washington and an MBA from the University of Washington.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
06/03/2026 38.777 ( 0 % ) 8 M $ 31/05/2026

Cargos activos de Scott Reents

EmpresasCargoInicio
TOBIRA THERAPEUTICS INC Director Financiero/CFO -
ABBVIE INC. Director Financiero/CFO 23/06/2022
ALLERGAN, INC. Presidente -
CEREVEL THERAPEUTICS HOLDINGS, INC. Presidente 01/08/2024
LANDOS BIOPHARMA, INC. Presidente -
PHARMACYCLICS, INC. Corporate Officer/Principal -
Presidente -
Presidente -
Presidente -

Antiguos cargos conocidos de Scott Reents.

EmpresasCargoFin
░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ -
Ver el detalle de la experiencia de Scott Reents.

Formación de Scott Reents.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

36

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN